MediWound Ltd.
NASDAQ:MDWD
19.5 (USD) • At close February 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 18.686 | 26.496 | 23.763 | 21.763 | 31.789 | 3.401 | 2.496 | 1.558 | 0.601 | 0.259 | 0 | 0 | 0 |
| Cost of Revenue
| 15.108 | 13.331 | 14.992 | 14.218 | 11.849 | 2.088 | 1.578 | 2.158 | 2.519 | 2.785 | 0 | 0 | 0 |
| Gross Profit
| 3.578 | 13.165 | 8.771 | 7.545 | 19.94 | 1.313 | 0.918 | -0.6 | -1.918 | -2.526 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.191 | 0.497 | 0.369 | 0.347 | 0.627 | 0.386 | 0.368 | -0.385 | -3.191 | -9.753 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 7.467 | 10.181 | 10.256 | 7.698 | 4.969 | 4.072 | 5.462 | 7.068 | 6.021 | 5.349 | 3.635 | 1.557 | 3.021 |
| General & Administrative Expenses
| 8.574 | 8.332 | 6.109 | 8.687 | 9.306 | 7.987 | 9.143 | 12.487 | 13.288 | 4.723 | 1.63 | 1.14 | 1.242 |
| Selling & Marketing Expenses
| 2.803 | 2.039 | 3.388 | 3.228 | 4.064 | 4.188 | 5.362 | 8.403 | 9.284 | 8.829 | 2.259 | 0 | 0 |
| SG&A
| 11.377 | 10.371 | 9.736 | 8.687 | 9.306 | 7.987 | 9.143 | 12.487 | 13.288 | 13.552 | 3.889 | 1.14 | 1.242 |
| Other Expenses
| 0.024 | 0.958 | -0.71 | -0.144 | 1.172 | -0.751 | 0.056 | 0.066 | 0.059 | 0.049 | 0.057 | 0.033 | 0.024 |
| Operating Expenses
| 18.868 | 21.51 | 19.992 | 16.385 | 15.447 | 5.273 | 14.605 | 19.555 | 19.309 | 18.901 | 7.581 | 2.73 | 4.287 |
| Operating Income
| -15.29 | -8.345 | -11.221 | -8.84 | 4.493 | -3.96 | -13.687 | -20.155 | -21.227 | -21.427 | -7.581 | -2.73 | -4.287 |
| Operating Income Ratio
| -0.818 | -0.315 | -0.472 | -0.406 | 0.141 | -1.164 | -5.484 | -12.936 | -35.319 | -82.73 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 8.759 | -11.176 | -2.303 | -0.436 | -2.427 | -1.705 | -0.846 | 1.27 | -0.444 | 2.552 | -0.92 | 14.715 | -0.532 |
| Income Before Tax
| -6.531 | -19.521 | -13.524 | -9.276 | 2.066 | -5.665 | -14.533 | -18.885 | -21.671 | -18.875 | -8.501 | 11.985 | -4.819 |
| Income Before Tax Ratio
| -0.35 | -0.737 | -0.569 | -0.426 | 0.065 | -1.666 | -5.823 | -12.121 | -36.058 | -72.876 | 0 | 0 | 0 |
| Income Tax Expense
| 0.185 | 0.078 | 0.027 | 0.325 | -1.652 | -9.689 | 8.462 | -1.27 | 0.861 | -2.552 | 7.77 | -13.67 | 1.882 |
| Net Income
| -6.716 | -19.599 | -13.551 | -9.601 | 3.718 | -1.057 | -22.149 | -18.885 | -22.088 | -18.875 | -15.351 | 10.94 | -6.169 |
| Net Income Ratio
| -0.359 | -0.74 | -0.57 | -0.441 | 0.117 | -0.311 | -8.874 | -12.121 | -36.752 | -72.876 | 0 | 0 | 0 |
| EPS
| -0.75 | -3.93 | -3.48 | -2.47 | 0.96 | -0.27 | -6.64 | -6.05 | -7.13 | -6.65 | -5.28 | 3.76 | -2.12 |
| EPS Diluted
| -0.75 | -3.93 | -3.48 | -2.47 | 0.96 | -0.27 | -6.64 | -6.05 | -7.13 | -6.65 | -5.28 | 3.76 | -2.12 |
| EBITDA
| -4.893 | -18.088 | -11.221 | -7.75 | 3.423 | -5.088 | -13.12 | -18.296 | -20.724 | -18.326 | -6.497 | 12.253 | -4.096 |
| EBITDA Ratio
| -0.262 | -0.352 | -0.42 | -0.356 | 0.177 | -0.995 | -5.256 | -12.558 | -34.483 | -62.819 | 0 | 0 | 0 |